Both in Pharmaceuticals
Exicure vs Aprea Therapeutics
Over the past year XCUR returned −75.8% and APRE returned −64.9%; their daily moves had a correlation of -0.09.
XCUR −75.8% APRE −64.9%Growth of $1, one year, split-adjusted
| Metric | XCUR | APRE |
|---|---|---|
| Price | $1.02 | $0.4910 |
| Market cap | $6.7M | $6.2M |
| Today | +0.99% | +1.32% |
| 1 month | −11.3% | −29.4% |
| 6 months | −68.6% | −41.6% |
| Year to date | −81.2% | −42.4% |
| 1 year | −77.0% | −66.1% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,192.3× |
| Net cash | $1.7M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 87.3% | 95.4% |
| Short % of float | 1.1% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).